Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
NVIV holding history
Invivo Therapeutics Holdings Corp. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVIV overviewAll 13F holders of NVIVFull Q4 2025 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −31,238−100.0% | Sold out | Holders |
| Q4 2023 | 31,238 | $22.8K | <0.1% | +2,300+7.9% | Added | Holders |
| Q3 2023 | 28,938 | $32.4K | <0.1% | +2,692+10.3% | Added | Holders |
| Q2 2023 | 26,246 | $35.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 26,246 | $27.8K | <0.1% | +9,300+54.9% | Added | Holders |
| Q4 2022 | 16,946 | $39.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 16,946 | $73.0K | <0.1% | +16,946 | New | Holders |